Download PDF
Thromb Haemost 2003; 90(06): 1216-1217
DOI: 10.1055/s-0037-1613427
Letters to the Editor
Schattauer GmbH

Thrombolysis in pregnancy

Raj K. Patel
,
Omotayo Fasan
,
Roopen Arya
Further Information

Publication History

Received 01 June 2003

Accepted after resubmission 05 August 2003

Publication Date:
09 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Department of Health, Welsh Office, Scottish Home and Health Department and Department of Health and Social Services Northern Ireland. London: Why Mothers Die 1997-1999. The fifth report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. HMSO. 2001
    PubMedGoogle Scholar
  • 2 Eldor A. Thrombophilia, thrombosis and pregnancy. Thromb Haemost 2001; 86 (01) 104-11.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 British Committee for Standards in Haematol-ogy. Guidelines on the prevention, investigation and management of thrombosis associated with pregnancy. J Clin Path 1993; 46: 489-96.
    CrossrefPubMedGoogle Scholar
  • 4 Royal College of Obstetricians and Gynaecologists. Thromboembolic Disease in Pregnancy and the Puerperium: Acute Management. Guideline No 28. London: RCOG. 2001
    PubMedGoogle Scholar
  • 5 Ginsberg JS. Use of Antithrombotic Agents During Pregnancy. Chest 2001; 119: 122S-131S.
    CrossrefPubMedGoogle Scholar
  • 6 Kearnon C. Initial Treatment of Venous Thromboembolism. Thromb Haemost 1999; 82 (02) 887-91.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Goldbauer SZ, Haire WD, Feldstein ML. et al. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right ventricular function and pulmonary perfusion. Lancet 1993; 341: 507-11.
    CrossrefPubMedGoogle Scholar
  • 8 Dalla-Volta S, Palla A, Santolicandro A. et al. Alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen Activator Italian Multicentre Study 2. J Am Coll Cardiol 1992; 20: 520-6.
    CrossrefPubMedGoogle Scholar
  • 9 The Urokinase Pulmonary Embolism Trial. A cooperative study. Circulation 1973; 47: II-1-108.
    CrossrefPubMedGoogle Scholar
  • 10 Ginsberg JS, Kowalchuk G, Hirsh J. et al. Heparin therapy during pregnancy. Risks to the fetus and mother. Arch Intern Med 1989; 149: 2233-6.
    CrossrefPubMedGoogle Scholar
  • 11 Hull R, Hirsh J, Jay R. et al. Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. N Engl J Med 1982; 307: 1676-81.
    CrossrefPubMedGoogle Scholar
  • 12 Hull R, Delmore T, Carter C. et al. Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis. N Engl J Med 1982; 306: 189-94.
    CrossrefPubMedGoogle Scholar
  • 13 Kanter DS, Mikkola KM, Patel SR. et al. Thrombolytic therapy for pulmonary embolism. Frequency of intacranial haemorrhage and associated risk factors. Chest 1997; 111: 1241-5.
    CrossrefPubMedGoogle Scholar
  • 14 Goldhaber SZ. A contemporary approach to thrombolytic therapy for pulmonary embolism. Vasc Med 2000; 5: 115-23.
    CrossrefPubMedGoogle Scholar
  • 15 Pfeifer GW. Distribution studies on placental transfer of 131 I Streptokinase during labor. Arch Gynekol 1969 207 (04) Suppl 550-8.
    PubMedGoogle Scholar
  • 16 Leeander I, Nilsson M, Astedt B. Depression of plasminogen activator activity during pregnancy by the placental inhibitor PAI 2. Fibrinolysis 1988; 2: 165-7.
    PubMedGoogle Scholar
  • 17 Konstantinides S, Geibel A, Heusel G. et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. Management Strategies and Prognosis of Pulmonary Embolism-3 Trial Investigators. N Engl J Med 2002; 347 (15) 1143-50.
    CrossrefPubMedGoogle Scholar